Novogen to Present at Asia Biotech Invest on May 20, 2015 at 10:00 AM

Novogen Limited

, announced today that company CEO, Dr Graham Kelly, will be a presenting company at Asia Biotech Invest 2015 May 20-21. The Novogen presentation is at 10.00 am May 20 at the Sheraton Hotel and Towers, Hong Kong. The event is co-delivered by AusBiotech and Beacon Events, and supported by partners including ChinaBio Group, HKBio, ASX and Austrade. Information about the program, speaker line up and spotlight company presentations is available at www.asiabiotechinvest.com Novogen CEO, Graham Kelly, said, "This week represents our inaugural exposure of the Company to the Asian investment market. A review of our share registry has revealed a growing and significant level of shareholding out of Asia, so the conference presents a timely opportunity to start highlighting the Novogen story to this enormous investment market. The conference presentation will be accompanied by a road-show to institutional investors in Hong Kong. With our need for funds well on the way to being satisfied, it is now a case of highlighting the investment opportunity by on-market buying in the Company's two first-in-class technology platforms."